tiprankstipranks
Advertisement
Advertisement

CERO Stock Latest News

CERo Therapeutics Amends Convertible Note, Expands Private Financing
Company AnnouncementsCERo Therapeutics Amends Convertible Note, Expands Private Financing
14d ago
8K
CERO
CERo Therapeutics Raises Funding via Convertible Note Financing
PremiumCompany Announcements
CERo Therapeutics Raises Funding via Convertible Note Financing
1M ago
8K
CERO
CERo Therapeutics Raises Capital via Convertible Note Financing
PremiumCompany Announcements
CERo Therapeutics Raises Capital via Convertible Note Financing
2M ago
8K
CERO
CERo Therapeutics Secures Convertible Note Financing Facility
PremiumCompany Announcements
CERo Therapeutics Secures Convertible Note Financing Facility
3M ago
8K
CERO
CERo Therapeutics Delays 2025 Annual Report Filing
PremiumCompany Announcements
CERo Therapeutics Delays 2025 Annual Report Filing
3M ago
CERO
Cero Therapeutics issues letter to shareholders
PremiumThe FlyCero Therapeutics issues letter to shareholders
4M ago
CERO
CERo Therapeutics Enters Convertible Note Financing Agreement
Premium
Company Announcements
CERo Therapeutics Enters Convertible Note Financing Agreement
4M ago
8K
CERO
Cero Therapeutics appoints Eric Francois to board of directors
Premium
The Fly
Cero Therapeutics appoints Eric Francois to board of directors
5M ago
CERO
SCYX
CERo Therapeutics Announces Convertible Note Financing and New Director
PremiumCompany Announcements
CERo Therapeutics Announces Convertible Note Financing and New Director
5M ago
8K
CERO
Cero Therapeutics to present data from Phase 2 trial of CER-1236
PremiumThe Fly
Cero Therapeutics to present data from Phase 2 trial of CER-1236
5M ago
CERO
CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial
PremiumCompany Announcements
CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial
5M ago
8K
CERO
CERo Therapeutics reports encouraging early CERTAINT-1 trial data
PremiumCompany Announcements
CERo Therapeutics reports encouraging early CERTAINT-1 trial data
6M ago
8K
CERO
Cero Therapeutics provides update on Phase 1 trial of CER-1236
PremiumThe FlyCero Therapeutics provides update on Phase 1 trial of CER-1236
6M ago
CERO
CERo Therapeutics shareholders approve key capital structure changes
Premium
Company Announcements
CERo Therapeutics shareholders approve key capital structure changes
7M ago
8K
CERO
Cero Therapeutics provides update on Phase 1 trial of CER-1236
Premium
The Fly
Cero Therapeutics provides update on Phase 1 trial of CER-1236
7M ago
CERO
CERo Therapeutics Enters New $14.6M Stock Agreement
PremiumCompany Announcements
CERo Therapeutics Enters New $14.6M Stock Agreement
7M ago
8K
CERO
Cero Therapeutics announces trading on OTCQB Market
PremiumThe Fly
Cero Therapeutics announces trading on OTCQB Market
7M ago
CERO
Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital
PremiumThe Fly
Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital
8M ago
CERO
CERo Therapeutics Delays Quarterly Report Filing
PremiumCompany Announcements
CERo Therapeutics Delays Quarterly Report Filing
8M ago
CERO
Cero Therapeutics initiates second cohort in Phase 1 trial of CER-1236
PremiumThe FlyCero Therapeutics initiates second cohort in Phase 1 trial of CER-1236
8M ago
CERO
Cero Therapeutics to present data on CER-1236 at SITC conference
Premium
The Fly
Cero Therapeutics to present data on CER-1236 at SITC conference
8M ago
CERO
Cero Therapeutics announces listing on OTC Markets
Premium
The Fly
Cero Therapeutics announces listing on OTC Markets
8M ago
CERO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >